Haemolytic-uraemic syndrome caused by vero toxin-producing Escherichia coli serotype Rough: K-: H49. 1999

M Keskimäki, and Y Ratiner, and S Oinonen, and E Leijala, and M Nurminen, and M Saari, and A Siitonen
National Public Health Institute, Laboratory of Enteric Pathogens, Helsinki, Finland.

The first case of haemolytic-uraemic syndrome (HUS) caused by Vero toxin-producing Escherichia coli (VTEC) which belonged to a novel serotype, Rough: K-: H49, is reported. The case was initially diagnosed as nephropathia epidemica caused by Puumala virus, but the subsequent diagnosis of HUS caused by VTEC was made after bacteriological investigation. The strain isolated fermented sorbitol produced VT2 toxin but not enterohaemolysin, nor did it carry the eaeA gene. In VTEC strains, the O antigen, the eaeA gene and enterohaemolysin production have been characterized as virulence-associated factors and believed to have an effect on pathogenesis of these strains to cause haemorrhagic colitis or HUS. The findings of this study demonstrate that there is a need for further studies to evaluate the pathogenetic mechanism of VTEC and need for easy diagnostic methods exploiting other properties than O157 antigen and non-fermentation of sorbitol to find all VTEC in human infections.

UI MeSH Term Description Entries
D008297 Male Males
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D006463 Hemolytic-Uremic Syndrome A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE. Gasser's Syndrome,Gasser Syndrome,Gassers Syndrome,Hemolytic Uremic Syndrome,Syndrome, Hemolytic-Uremic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001427 Bacterial Toxins Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases. Bacterial Toxin,Toxins, Bacterial,Toxin, Bacterial
D012703 Serotyping Process of determining and distinguishing species of bacteria or viruses based on antigens they share. Serotypings
D022641 Shiga Toxin 2 A toxin produced by certain pathogenic strains of ESCHERICHIA COLI such as ESCHERICHIA COLI O157. It shares 50-60% homology with SHIGA TOXIN and SHIGA TOXIN 1. SLT-II,SLTII,Shiga Like Toxin II,Shiga Toxin 2, Escherichia coli,Shiga-Like Toxin II,Stx2 protein,VT2 Cytotoxin,Vero Cytotoxin VT2,Verotoxin 2,Cytotoxin, VT2,SLT II

Related Publications

M Keskimäki, and Y Ratiner, and S Oinonen, and E Leijala, and M Nurminen, and M Saari, and A Siitonen
January 2005, Lancet (London, England),
M Keskimäki, and Y Ratiner, and S Oinonen, and E Leijala, and M Nurminen, and M Saari, and A Siitonen
January 2011, Nederlands tijdschrift voor geneeskunde,
M Keskimäki, and Y Ratiner, and S Oinonen, and E Leijala, and M Nurminen, and M Saari, and A Siitonen
April 2021, Epidemiology and infection,
M Keskimäki, and Y Ratiner, and S Oinonen, and E Leijala, and M Nurminen, and M Saari, and A Siitonen
April 2016, Epidemiology and infection,
M Keskimäki, and Y Ratiner, and S Oinonen, and E Leijala, and M Nurminen, and M Saari, and A Siitonen
May 1995, The Journal of infection,
M Keskimäki, and Y Ratiner, and S Oinonen, and E Leijala, and M Nurminen, and M Saari, and A Siitonen
January 1990, Infection,
M Keskimäki, and Y Ratiner, and S Oinonen, and E Leijala, and M Nurminen, and M Saari, and A Siitonen
May 2019, BMC nephrology,
M Keskimäki, and Y Ratiner, and S Oinonen, and E Leijala, and M Nurminen, and M Saari, and A Siitonen
June 1998, The Medical journal of Australia,
M Keskimäki, and Y Ratiner, and S Oinonen, and E Leijala, and M Nurminen, and M Saari, and A Siitonen
June 1984, Lancet (London, England),
M Keskimäki, and Y Ratiner, and S Oinonen, and E Leijala, and M Nurminen, and M Saari, and A Siitonen
April 1988, Journal of medical microbiology,
Copied contents to your clipboard!